A Study of RO7617991 in Patients With Locally Advanced or Metastatic MAGE-A4-Positive Solid Tumors

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped GO44669 study has been withdrawn due to an internal Sponsor decision. The decision was not due to any safety or efficacy concerns with the study drug.

Conditions

Refractory Cancer
Recurrent Cancer
Solid Tumor, Adult

Interventions

DRUG: RO7617991
DRUG: Tocilizumab

Sponsor

Genentech, Inc.